Chargement en cours...
A Novel Approach to Screening for New Neuroprotective Compounds for the Treatment of Stroke
Despite the significant advances that have been made in understanding the pathophysiology of cerebral ischemia on the cellular and molecular level, only one drug, the thrombolytic tissue plasminogen activator (rt-PA), is approved by the FDA for use in patients with acute ischemic stroke. Therefore,...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2111291/ https://ncbi.nlm.nih.gov/pubmed/17765210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2007.07.061 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|